Urologic oncology

Machine Name

Urologic oncology

What is the best way not to treat prostate cancer?

Read more about What is the best way not to treat prostate cancer?

Utility of novel androgen receptor therapies in the real world: A nuanced approach.

Read more about Utility of novel androgen receptor therapies in the real world: A nuanced approach.

Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy.

Read more about Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy.

Approaches to minimize castration in the treatment of advanced prostate cancer.

Read more about Approaches to minimize castration in the treatment of advanced prostate cancer.

Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review.

Read more about Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review.

Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings.

Read more about Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings.

Agent Orange and long-term outcomes after radical prostatectomy.

Read more about Agent Orange and long-term outcomes after radical prostatectomy.

Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer.

Read more about Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer.

The future of quality in urologic oncology: evaluating the horizon of surgical standards.

Read more about The future of quality in urologic oncology: evaluating the horizon of surgical standards.

Commentary on "Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study." Schutz FA, Pomerantz MM, Gray KP, Atkins MB, Rosenberg JE, Hirsch MS, McDermott DF, Lampron ME, Lee GS, Signoretti S, Kantoff PW, Freedman ML,

Read more about Commentary on "Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study." Schutz FA, Pomerantz MM, Gray KP, Atkins MB, Rosenberg JE, Hirsch MS, McDermott DF, Lampron ME, Lee GS, Signoretti S, Kantoff PW, Freedman ML,

Subscribe to Urologic oncology